Inventor
BUHR CHRIS A
US18 patents
⚠️ This page may combine multiple inventors who share the name “BUHR CHRIS A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GILEAD SCIENCES INC
4 patentsUS5792847AAug 11, 1998
2' Modified Oligonucleotides
GILEAD SCIENCES INC529 citations99
US5486603AJan 23, 1996
Oligonucleotide having enhanced binding affinity
GILEAD SCIENCES INC954 citations99
US5565555AOct 15, 1996
Nucleoside hydrogen phosphonodithioate diesters and activated phosphonodithioate analogues
GILEAD SCIENCES INC383 citations98
US5194599AMar 16, 1993
Hydrogen phosphonodithioate compositions
GILEAD SCIENCES INC463 citations98
ISIS PHARMACEUTICALS INC
3 patentsUS6476205B1Nov 5, 2002
2′ Modified oligonucleotides
ISIS PHARMACEUTICALS INC305 citations99
US6911540B2Jun 28, 2005
2′ Modified oligonucleotides
ISIS PHARMACEUTICALS INC3 citations63
US6756496B1Jun 29, 2004
Nucleoside hydrogen phosphonodithioate diesters and activated phosphonodithioate analogues
ISIS PHARMACEUTICALS INC3 citations62
EXELIXIS INC
3 patentsSIGNAL PHARM LLC
3 patentsUS7220771B2May 22, 2007
Methods of using indazole derivatives as JNK inhibitors
SIGNAL PHARM LLC22 citations91
US7211594B2May 1, 2007
Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith
SIGNAL PHARM LLC23 citations91
US7208513B2Apr 24, 2007
Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith
SIGNAL PHARM LLC16 citations91
BAIK TAE-GON
3 patentsUS8101622B2Jan 24, 2012
Pyridopyrimidinone inhibitors of PI3Kα and mTOR
BAIK TAE-GON10 citations81
US8247408B2Aug 21, 2012
Pyridopyrimidinone inhibitors of PI3Kα for the treatment of cancer
BAIK TAE-GON10 citations80
US8710038B2Apr 29, 2014
Pyrazole kinase modulators and methods of use
BAIK TAE-GON0 citations38